Synthesis of evidence for reimbursement decisions: a Bayesian reanalysis.

about

Synthesis of evidence for reimbursement decisions: a Bayesian reanalysis.

Item

http://www.wikidata.org/entity/Q50179577

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Synthesis of evidence for reimbursement decisions: a Bayesian reanalysis.

@en

Synthesis of evidence for reimbursement decisions: a Bayesian reanalysis.

@nl

type

Item

label

Synthesis of evidence for reimbursement decisions: a Bayesian reanalysis.

@en

Synthesis of evidence for reimbursement decisions: a Bayesian reanalysis.

@nl

prefLabel

Synthesis of evidence for reimbursement decisions: a Bayesian reanalysis.

@en

Synthesis of evidence for reimbursement decisions: a Bayesian reanalysis.

@nl

P1476

Synthesis of evidence for reimbursement decisions: a Bayesian reanalysis.

@en

P2093

Rene Sluiter

http://www.w3.org/2001/XMLSchema#string

Willem Woertman

http://www.w3.org/2001/XMLSchema#string

P2860

Combination of direct and indirect evidence in mixed treatment comparisons

Using full probability models to compute probabilities of actual interest to decision makers.

Bayesian methods in meta-analysis and evidence synthesis.

Who's afraid of Thomas Bayes?

Evidence based policy decisions through a Bayesian approach: the case of a statin appraisal in The Netherlands.

Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes.

Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea.

Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes.

Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial

Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus.

P304

438-445

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/S0266462314000385

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gert Jan van der Wilt

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25425179

http://www.w3.org/2001/XMLSchema#string